Expert: Though Patients Don’t Always See Savings With Biosimilars, New Policies Could Improve Access
May 15th 2023Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.
Watch
Novel Treatment Achieves Up to 14.9% Weight Loss After 46 Weeks
May 12th 2023BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.
Read More